5 not yet recruiting. 5 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 5 | Not yet recruiting 5 |
Follow Bronchitis: new trials by email Literature Review of Bronchitis trials Research Report on Bronchitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The LalelaLung Study: Digital Stethoscope Clinical Evaluation StethoMe AI-enabled digital stethoscope system, Standard IMCI assessment - Pneumonia, Tuberculosis, Pulmonary | Phase 4 | Not yet recruiting | Johns Hopkins University | 350 | 2026-11-02 | 2026-09-23 |
| A Study to Investigate Safety of Belumosudil in Participants Aged 12 Years and Above, With Chronic Graft-versus-host Disease (cGVHD) Belumosudil - Chronic Graft Versus Host Disease | Phase 4 | Not yet recruiting | Sanofi | 26 | 2026-10-30 | 2026-10-23 |
| Study to Evaluate the Effects of Oral Glyceryl Guiacolate (Guaifenesin, GGE) on Sputum Rheology in Subjects With Mucus Hypersecretion Glycerol Guiacolate, SOC (Standard of care) - Bronchitis, Bronchitis, Chronic | Phase 4 | Not yet recruiting | University of North Carolina, Chapel Hill | 40 | 2026-10-01 | 2026-10-14 |
| Entecavir With or Without Pegylated Interferon α-2b in Children Aged 3-6 Years With Immune-Tolerant Chronic Hepatitis B Entecavir, Entecavir + Pegylated interferon α-2b - Hepatitis B Virus Infection, Children | Phase 4 | Not yet recruiting | Qing-Lei Zeng | 80 | 2026-01-11 | 2026-01-16 |
| Entecavir With or Without Pegylated Interferon α-2b in Children Aged 3-6 Years With Immune-Active Chronic Hepatitis B Entecavir, Entecavir + Pegylated interferon α-2b - Hepatitis B Virus Infection, Children | Phase 4 | Not yet recruiting | Qing-Lei Zeng | 60 | 2026-01-11 | 2026-01-16 |
Bronchiolitis Obliterans Syndrome (3) · Hepatitis B (2) · Hepatitis B, Chronic (2) · Bronchiolitis (1) · Bronchitis, Chronic (1) · Pneumonia (1) · Respiratory Sounds (1) · Respiratory Tract Infections (1) · Tuberculosis, Pulmonary (1)
Bronchial Diseases (5) · Lung Diseases (5) · Lung Diseases, Obstructive (5) · Respiratory Tract Diseases (5) · Infections (4) · Pathological Conditions, Signs and Symptoms (4) · Bronchiolitis (3) · Bronchiolitis Obliterans (3) · Chronic Disease (3) · Disease Attributes (3) · Graft vs Host Disease (3) · Immune System Diseases (3) · Organizing Pneumonia (3) · Pathologic Processes (3)
entecavir (2) · Acetylcysteine (1) · Standard of Care (1) · belumosudil (1)
Qing-Lei Zeng (2) · Johns Hopkins University (1) · Sanofi (1) · University of North Carolina, Chapel Hill (1)
United States (1)
Qing-Lei Zeng, M.D. (2) · Brian Button, PhD (1) · Eric McCollum, MD, MPH (1)
R33HD109804 (1)